Iris Faull Fleischer is the Group Chief Medical Officer at SYNLAB International, bringing over 20 years of experience in diagnostics, with a focus on precision medicine and oncology. Iris has held various medical and business development roles across Europe, South America, Canada, and the Middle East, and has successfully achieved reimbursement wins and guideline adoptions for cancer diagnostic tests. Iris was the founder of Livemedix Health and has served as a Country Manager at NanoString Technologies, where they developed the adoption of innovative technologies in oncology. With an extensive education background, including a Master in Healthcare Services Management, Iris is dedicated to advancing healthcare and improving disease management globally.
Location
Greater Barcelona Metropolitan Area, Spain